A 4-month, open-label, multi-center study to explore tolerability and safety and health outcomes of FTY720 in patients with relapsing forms of multiple sclerosis.

The requested reference [15f2a2ca40d6f2fd3b484ab7ee1e4d28b316d162] no longer exists in our database. It has been replaced by the current reference: [f2629013bfbec5104b02f52a4ed7b3b42fbca2ab]

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2010
This article has no abstract
Epistemonikos ID: 8fb4f25c15c486a755d5adb05e63ca81fd406d5b
First added on: Apr 17, 2025